1. Nashold BS Jr, Goldner JL, Mullen JB, Bright DS. Long-term pain control by direct peripheral-nerve stimulation. J Bone Joint Surg Am. 1982; 64:1–10.
Article
2. Kim WH, Kim HJ, Kim SH, Jung JH, Park HY, Lee J, et al. Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study. BMC Cancer. 2019; 19:859. DOI:
10.1186/s12885-019-6095-1.
Article
3. Helvie MA, Ikeda DM, Adler DD. Localization and needle aspiration of breast lesions: complications in 370 cases. AJR Am J Roentgenol. 1991; 157:711–714. DOI:
10.2214/ajr.157.4.1892023.
Article
4. Czarnecki DJ, Feider HK, Splittgerber GF. Toluidine blue dye as a breast blocalization marker. AJR Am J Roentgenol. 1989; 153:261–263. DOI:
10.2214/ajr.153.2.261.
5. Saarela AO, Kiviniemi HO, Rissanen TJ. Preoperative methylene blue staining of galactographically suspicious breast lesions. Int Surg. 1997; 82:403–405.
6. Sewak S, Graham P, Nankervis J. Tattoo allergy in patients receiving adjuvant radiotherapy for breast cancer. Australas Radiol. 1999; 43:558–561. DOI:
10.1046/j.1440-1673.1999.00733.x.
Article
7. Soran A, Kanbour-Shakir A, Bas O, Bonaventura M. A tattoo pigmented node and breast cancer. Bratisl Lek Listy. 2014; 115:311–312. DOI:
10.4149/BLL_2014_063.
Article
8. Lager DJ, O'Connor JC, Robinson RA, Brown RC, Urdaneta LF. Factitious microcalcifications in breast biopsy material: laboratory-induced error by use of tattoo powder for specimen mammography. J Surg Oncol. 1989; 40:281–282. DOI:
10.1002/jso.2930400415.
Article
9. Vilska J. [Indications and contra-indications of activated charcoal in a poison control center. The viewpoint of the Poison Control Center of Finland]. J Toxicol Clin Exp. 1989; 9:295–298. French.